Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
Actinic prurigo is a chronic familial photodermatosis that occurs mostly in Amerindians. Eight patients with actinic prurigo were given intermittent 3- to 14-day courses of topical 0.05% clobetasol 17-propionate cream or ointment in 1988 and 1989. Seven out of eight patients cleared or markedly improved. All of the patients had been resistant previously to milder topical corticosteroids. There have been no side effects. This therapy offers an effective alternative to systemic corticosteroids, oral psoralen with long-wave UV radiation in the A range, or thalidomide.
Department of Medicine, University Hospital, University of Saskatchewan, Saskatoon, Canada.
P R
PR
Lane
A A
AA
Moreland
D J
DJ
Hogan
D000287:Administration, Topical; D000293:Adolescent; D001623:Betamethasone / Q000031:analogs & derivatives*; D002648:Child; D002990:Clobetasol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000188:drug therapy*; D011536:Prurigo / Q000188:drug therapy* / Q000209:etiology; D013472:Sunlight / Q000009:adverse effects
D001623:Betamethasone; D002990:Clobetasol